What are the benefits of using real-world data in clinical evaluations?

Real-world data can provide more applicable evidence in varied patient populations, showcasing the effectiveness and safety of new therapies in real-world settings.

How can InfinixBio assist with integrating RWD into research strategies?

InfinixBio is equipped to provide extensive support throughout the drug development lifecycle, including consultancy on how real-world evidence influences protocol design adjustments, ensuring compliance and robust evaluation frameworks.

Why is diversity in clinical trials important?

Incorporating diverse populations in clinical trials improves generalizability and ensures that findings can be applied across different demographics. Learn more about this topic in our article on why diversity in clinical trials improves generalizability.